CHNG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CHNG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Change Healthcare's annualized ROCE % for the quarter that ended in Jun. 2022 was 1.11%.
The historical data trend for Change Healthcare's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change Healthcare Annual Data | |||||||||||||||
Trend | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | |||||||||
ROCE % | Get a 7-Day Free Trial | -4.27 | -5.33 | -20.78 | 1.08 | 1.43 |
Change Healthcare Quarterly Data | |||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | |
ROCE % | Get a 7-Day Free Trial | 2.09 | 0.28 | 1.08 | 2.30 | 1.11 |
Change Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2022 is calculated as:
ROCE % | = | EBIT | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(A: Mar. 2022 ) | (A: Mar. 2021 ) | (A: Mar. 2022 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(A: Mar. 2022 ) | (A: Mar. 2021 ) | (A: Mar. 2022 ) | |||||
= | 128.243 | / | ( ( (10112.616 - 1047.121) | + | (9932.495 - 1079.666) ) | / 2 ) | |
= | 128.243 | / | ( (9065.495 | + | 8852.829) | / 2 ) | |
= | 128.243 | / | 8959.162 | ||||
= | 1.43 % |
Change Healthcare's ROCE % of for the quarter that ended in Jun. 2022 is calculated as:
ROCE % | = | EBIT (1) | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(Q: Jun. 2022 ) | (Q: Mar. 2022 ) | (Q: Jun. 2022 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(Q: Jun. 2022 ) | (Q: Mar. 2022 ) | (Q: Jun. 2022 ) | |||||
= | 97.564 | / | ( ( (9932.495 - 1079.666) | + | (9636.981 - 932.805) ) | / 2 ) | |
= | 97.564 | / | ( ( 8852.829 | + | 8704.176 ) | / 2 ) | |
= | 97.564 | / | 8778.5025 | ||||
= | 1.11 % |
(1) Note: The EBIT data used here is four times the quarterly (Jun. 2022) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change Healthcare (NAS:CHNG) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Thank you for viewing the detailed overview of Change Healthcare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Tracy Byers | officer: SVP and GM, Enterprise Imaging | C/O CHANGE HEALTHCARE INC. 424 CHURCH STREET, SUITE 1400 NASHVILLE TN 37219 |
Steven B. Martin | officer: EVP, Enterprise Technology | 3055 LEBANON PIKE SUITE 1000 NASHVILLE TN 37214 |
Nella Domenici | director | C/O ALLIANCEBERNSTEIN, 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105 |
Paul Rareshide | officer: SVP, Corporate Controller | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Fredrik J Eliasson | officer: EVP & CFO | 500 WATER STREET, JACKSONVILLE FL 32202 |
De Crescenzo Neil E. | director, officer: President & CEO | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Diana Mckenzie | director | METLIFE, 200 PARK AVENUE, NEW YORK NY 10166 |
Roderick H. O'reilly | officer: See Remarks | C/O CHANGE HEALTHCARE INC., 3055 LEBANON PIKE, SUITE 1000, NASHVILLE TN 37214 |
August Calhoun | officer: See Remarks | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Thomas Mcenery | officer: EVP & Chief Marketing Officer | |
Bansi Nagji | director | MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039 |
Alex P. Choy | officer: See Remarks | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
Linda Whitley-taylor | officer: EVP & Chief People Officer | C/O BENSON HILL, INC., 1001 NORTH WARSON ROAD, SAINT LOUIS MO 63132 |
Phillip W. Roe | director | 20 BURTON HILLS BOULEVARD SUITE 100 NASHVILLE TN 37215 |
Kriten Joshi | officer: See Remarks | C/O CHANGE HEALTHCARE INC. 3055 LEBANON PIKE, SUITE 1000 NASHVILLE TN 37214 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 02-11-2023
By GuruFocus Research • 05-25-2023
By Business Wire Business Wire • 07-21-2022
By Business Wire Business Wire • 05-12-2022
By Business Wire Business Wire • 02-24-2022
By GuruFocus Research GuruFocus Editor • 01-27-2023
By GuruFocus Research GuruFocus Editor • 10-20-2022
By GuruFocus Research GuruFocus Editor • 11-15-2022
By GuruFocus Research GuruFocus Editor • 11-14-2022
By GuruFocus Research GuruFocus Editor • 02-18-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.